End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,185 KRW | +1.33% | +2.32% | +15.61% |
Feb. 16 | Easy Bio USA, Inc. announced that it expects to receive KRW 47.3286 billion in funding from EASY BIO,Inc. | CI |
2022 | EASY BIO,Inc.(KOSDAQ:A353810) dropped from S&P Global BMI Index | CI |
Sales 2022 | 156B 115M | Sales 2023 | 165B 122M | Capitalization | 124B 91.32M |
---|---|---|---|---|---|
Net income 2022 | 9.13B 6.75M | Net income 2023 | 15.54B 11.49M | EV / Sales 2022 | 1.15 x |
Net Debt 2022 | 40.85B 30.19M | Net Debt 2023 | 51.57B 38.11M | EV / Sales 2023 | 1.06 x |
P/E ratio 2022 |
15
x | P/E ratio 2023 |
7.96
x | Employees | 146 |
Yield 2022 |
1.86% | Yield 2023 |
2.76% | Free-Float | 52.32% |
1 day | +1.33% | ||
1 week | +2.32% | ||
Current month | +0.72% | ||
1 month | +13.26% | ||
3 months | +18.39% | ||
6 months | +30.78% | ||
Current year | +15.61% |
Managers | Title | Age | Since |
---|---|---|---|
Il-Hwan Hwang
CEO | Chief Executive Officer | 53 | - |
Ji-Bum Kim
CEO | Chief Executive Officer | 59 | - |
Jong-Cheol Kim
BRD | Director/Board Member | 55 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ji-Bum Kim
CEO | Chief Executive Officer | 59 | - |
Jong-Cheol Kim
BRD | Director/Board Member | 55 | - |
Il-Hwan Hwang
CEO | Chief Executive Officer | 53 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 4,185 | +1.33% | 141,536 |
24-05-13 | 4,130 | -1.08% | 131,735 |
24-05-10 | 4,175 | +2.45% | 177,421 |
24-05-09 | 4,075 | -0.61% | 184,300 |
24-05-08 | 4,100 | +0.24% | 78,686 |
End-of-day quote Korea S.E., May 13, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+15.61% | 105M | |
+16.90% | 12.26B | |
+1.93% | 6.04B | |
+6.97% | 5.37B | |
+13.27% | 4.96B | |
-20.30% | 2.74B | |
+3.62% | 1.92B | |
-15.20% | 1.28B | |
-10.63% | 958M | |
-20.72% | 957M |
- Stock Market
- Equities
- A353810 Stock